Abstract: To analyze the clinical characteristics of patients with Mucopolysaccharidosis ⅣA (MPS ⅣA). A retrospective study was conducted on 111 patients with MPS ⅣA in Xinhua Hospital of Shanghai Jiao Tong University School of Medcine from December 2008 to August 2020, confirmed by enzyme activity and genetic testing. General situation, clinical manifestations and enzyme activity test results were analyzed. According to the clinical manifestations, it can be divided into severe, intermediate and mild group. The independent sample test was used to compare the birth body length and weight of children with that of normal boys and girls, and group comparisons of enzyme activities were evaluated by median test. One hundred and eleven unrelated patients, 69 males and 42 females, were classified into 3 subtypes: severe (=85), intermediate (=14), and mild (=12). The age at symptom onset were 1.6 (1.0, 3.0) years, and at diagnosis were 4.3 (2.8, 7.8) years. Skeletal manifestations were observed in all patients and consisted mainly of pectus carinatum (96/111, 86.5%), motor dysfunction (78/111, 70.3%), spinal deformity (71/111, 64.0%), growth retardation (64/111, 57.7%), joint laxity (63/111, 56.8%) and genu valgum (62/111, 55.9%). Eighty-eight patients (88/111, 79.3%) with MPS ⅣA were also along with non-skeletal manifestations, mainly including snoring (38/111, 34.2%), coarse faces (34/111, 30.6%), and visual impairment (26/111, 23.4%). The most common skeletal manifestation was pectus carinatum (79 cases), and non-skeletal manifestation was snoring (30 cases) and coarse faces (30 cases) in severe patients, pectus carinatum (13 cases) and snoring (5 cases) in intermediate type, motor dysfunction (11 cases) and snoring (3 cases) and visual impairment (3 cases) in mild patients. The height and weight of severe patients began to fall below -2 at 2-<5 years and 5-<7 years, respectively. At the age of 10-<15 years, the standard deviation score of the height of severe patients reached (-6.2±1.6) in males and (-6.4±1.2) in females, and the score of weight got (-3.0±1.1) in males and (-3.5±0.5) in females. The height of intermediate patients began to fall below -2 at the age of 7-<10 years, and the standard deviation score of height were -4.6 and -3.6 in 2 males, and -4.6 and -3.8 in 2 females at the age of 10-<15 years. The weight remained within -2 in 72.0% (18/25) of intermediate patients compared to age-matched healthy children. In the mild patients with MPS ⅣA, the mean standard deviation score of height and weight was within -2 . The enzyme activities of mild patients (2.02 (1.05, 8.20) nmol/(17 h·mg)) were both significantly higher than that of intermediate (0.57 (0.47, 0.94) nmol/(17 h·mg)) and severe (0.22 (0, 0.59) nmol/(17 h·mg)) patients (=9.91, 13.98, =0.005, 0.001), and the enzyme activity of intermediate patients was significantly higher than that of severe patients (=8.56, =0.010). The clinical manifestations of MPS ⅣA are charactered by pectus carinatum, motor function impairment, spinal deformity and growth retardation. The clinical characteristics, growth rate and enzyme activity differ among the 3 subtypes of MPS ⅣA.

The significance of Mongolian spots for primary screening of Mucopolysaccharidosis

An At-Risk Population Screening Program For Mucopolysaccharidoses By Measuring Urinary Glycosaminoglycans In Taiwan

Updated Confirmatory Diagnosis for Mucopolysaccharidoses in Taiwanese Infants and the Application of Gene Variants

Phenotypic and genetic characteristics of 130 patients with mucopolysaccharidosis type II: A single-center retrospective study in China

Cardiac Evaluation using Two-Dimensional Speckle-Tracking Echocardiography and Conventional Echocardiography in Taiwanese Patients with Mucopolysaccharidoses

[Enzymatic Diagnosis of 47 Cases with Mucopolysaccharidosis].

Clinical characteristics and genotypes of 201 patients with mucopolysaccharidosis type II in China: A retrospective, observational study.

Newborn Screening Program for Mucopolysaccharidosis Type II and Long-Term Follow-Up of the Screen-Positive Subjects in Taiwan

Mucopolysaccharidosis III in Mainland China: natural history, clinical and molecular characteristics of 34 patients

The Relationships Between Urinary Glycosaminoglycan Levels and Phenotypes of Mucopolysaccharidoses

[Clinical characteristics of 111 cases with mucopolysaccharidosis ⅣA].

Identification of Eight Novel Mutations and Transcript Analysis of Two Splicing Mutations in Chinese Newborns with MCC Deficiency.

Clinical manifestations and genetic mutation analysis of patients with mucopolysaccharidosis type VII in China

Mucopolysaccharidosis type IIIC in chinese mainland: clinical and molecular characteristics of ten patients and report of six novel variants in the HGSNAT gene

Clinical Characteristics and Enzyme Assays of 35 Cases with Mucopolysaccharidosis Type IV

Identification of a distinct mutation spectrum in the SMPD1 gene of Chinese patients with acid sphingomyelinase-deficient Niemann-Pick disease

Identification and characterization of novel genetic variants in the first Chinese family of mucopolysaccharidosis IIIC (Sanfilippo C syndrome)

Relationships among Height, Weight, Body Mass Index, and Age in Taiwanese Children with Different Types of Mucopolysaccharidoses

The diagnosis and management of mucopolysaccharidosis type II

Ophthalmologic Manifestations in Taiwanese Patients with Mucopolysaccharidoses.

Natural History and Clinical Assessment of Taiwanese Patients with Mucopolysaccharidosis IVA